Page EC, Heatley SL, Eadie LN, McClure BJ, et al. HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort. Oncogene 2021 Dec 2. pii: 10.1038/s41388-021-02126.
PMID: 34857887